Rezolute (RZLT) Shares Outstanding (Diluted Average) (2013 - 2026)

Rezolute recorded quarterly Shares Outstanding (Diluted Average) of $103.7 million in Q1 2026, little changed quarter-over-quarter from $103.7 million in Q4 2025, and up 48.1% year-over-year from $70.0 million in Q1 2025.

Rezolute's Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $103.7 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 48.1% year-over-year to $103.7 million; the TTM figure through Mar 2026 stood at $103.7 million (up 48.1% YoY), while the FY2025 annual figure was $76.0 million, up 47.67% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $103.7 million for Q1 2026 at Rezolute, roughly flat from $103.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $103.7 million in Q1 2026 to a low of $13.7 million in Q1 2022.
  • A 5-year average of $61.1 million and a median of $51.4 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
  • Across the five-year window, Shares Outstanding (Diluted Average) soared 493.54% in 2022 and increased 0.19% in 2024, its largest moves.
  • Rezolute's Shares Outstanding (Diluted Average) stood at $51.0 million in 2022, then gained by 0.86% to $51.4 million in 2023, then soared by 36.05% to $69.9 million in 2024, then jumped by 48.25% to $103.7 million in 2025, then rose by 0.03% to $103.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $103.7 million, $103.7 million, and $103.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Rezolute 374.41 Mn 374.41 Mn - 103.71 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 103.71 Mn
Dec 31, 2025 103.69 Mn
Sep 30, 2025 103.42 Mn
Jun 30, 2025 76.00 Mn
Mar 31, 2025 70.03 Mn
Dec 31, 2024 69.94 Mn
Sep 30, 2024 69.74 Mn
Jun 30, 2024 51.47 Mn
Mar 31, 2024 51.21 Mn
Dec 31, 2023 51.41 Mn
Sep 30, 2023 51.41 Mn
Jun 30, 2023 51.19 Mn
Mar 31, 2023 51.11 Mn
Dec 31, 2022 50.97 Mn
Sep 30, 2022 50.53 Mn
Jun 30, 2022 19.49 Mn
Mar 31, 2022 13.75 Mn
Dec 31, 2021 15.68 Mn
Sep 30, 2021 8.51 Mn
Jun 30, 2021 7.67 Mn
Mar 31, 2021 7.45 Mn
Dec 31, 2020 8.05 Mn
Sep 30, 2020 5.87 Mn
Jun 30, 2014 9.38 Mn
Jun 30, 2013 6.20 Mn